Furthermore, BCAT2 has been described mainly as an important progressive factor of different kinds of cancer, including pancreatic and lung cancer, bladder cancer, as well as other diseases like Alzheimer’s disease or myeloid leukaemia [40,41] due to its mediating role in the regulation of metabolic-related pathways [42]. This evidence concerns the gene BCAT2 and urinary bladder carcinoma.